Kardium Inc.
Clinical trials sponsored by Kardium Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New heart device aims to zap away irregular rhythm Results expected Sep 2026 (estimated)
- New heart device aims to zap away irregular heartbeat Results expected May 2027 (estimated)
-
Zapping the heart back to rhythm: a new device uses pulsed fields to treat atrial fibrillation
Disease control Not yet recruitingThis study tests a device called the Globe Pulsed Field System, which uses short bursts of electric energy to destroy tiny areas of heart tissue that cause abnormal rhythms in people with paroxysmal atrial fibrillation (a type of irregular heartbeat that comes and goes). The tria…
Sponsor: Kardium Inc. • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New heart device registry aims to tame irregular heartbeat
Disease control Not yet recruitingThis registry will follow 500 people with symptomatic atrial fibrillation who are scheduled for a heart ablation using the Globe Pulsed Field System. The goal is to see how well the device controls the heart rhythm over 12 months and to track any major side effects within the fir…
Sponsor: Kardium Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC